HEALTHCARE

Introduction to TDDS: The human skin is the largest organ of the human body. The skin covers a surface of nearly two square meters and receives nearly one-third of the blood in the body. Delivering drugs to the body through the skin has proved to be one of the most effective means of drug delivery besides oral delivery of drugs and therefore has received greater attention from the pharmaceutical industry due to increasing demand for controlled drug delivery. Skin is one of the most readily accessible organs of the human body. There is considerable interest in the skin as a site of drug application both for local and systemic effect, a factor that has added considerable interest to the transdermal drug delivery systems market. The global Transdermal Drug Delivery Systems Market is expected to register a healthy CAGR over the forecast period. The market held a market value of USD 5,400.2 Million in 2017 and is projected to grow at a CAGR of 4.6% during the forecast period from 2...

Introduction to TDDS: The global Transdermal Drug Delivery Systems Market is expected to register a healthy CAGR over the forecast period. The market held a market value of USD 5,400.2 Million in 2017 and is projected to grow at a CAGR of 4.6% during the forecast period from 2018 to 2023. The human skin is the largest organ of the human body. The skin covers a surface of nearly two square meters and receives nearly one-third of the blood in the body. Delivering drugs to the body through the skin has proved to be one of the most effective means of drug delivery besides oral delivery of drugs and therefore has received greater attention from the pharmaceutical industry due to increasing demand for controlled drug delivery. Skin is one of the most readily accessible organs of the human body. There is considerable interest in the skin as a site of drug application both for local and systemic effect, a factor that has added considerable interest to the transdermal drug delivery sy...

Market Overview: Market Research Future (MRFR) states that the global Transdermal Drug Delivery Systems Market had created a value of USD 5,400.2 MN in 2017. This market value is expected to appreciate at a double-digit CAGR of 11.8% throughout the forecast period ( 2018 – 2023 ). Increasing cancer cases is a major driving force pushing upmarket growth. Transdermal Drug Delivery Systems (TDDS) are used to administer medications through the skin to the circulatory system. TDDS deliver drugs at a predetermined rate and maintain sufficient concentrations clinically to ensure a quick response. TDD devices are commonly used for pain management and during treatments of chronic diseases like cardiovascular diseases, cancer, and diabetes. The transdermal drug delivery systems market is growing rapidly over recent years, mainly due to the growing geriatric population and the prevalence of chronic diseases. Moreover, rapid advancements and increasing adoption of transdermal drug del...